Picture of Komipharm International Co logo

041960 Komipharm International Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

Annual cashflow statement for Komipharm International Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-23,267-3,957-5,934-7,480-5,911
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items8,7951,7621,9794,879405
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital2,149-1,520-883-3,034-673
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities95125.2-1,256-1,808-2,800
Capital Expenditures-6,679-1,685-1,184-1,065-1,129
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items115119439-310-2,373
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-6,563-1,566-745-1,376-3,502
Financing Cash Flow Items-2,765-647-1.11-37.9
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities5,361-1,640-1,0222,03410,531
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-295-3,830-3,057-1,1874,015